A recently published study from Tel Aviv University made headlines over the weekend for finding that a variant of coronavirus discovered in South Africa may be more resistant to the Pfizer/BioNTech vaccine. The study is not yet peer-reviewed. The study was featured on news websites with headlines saying the variant “may evade protection from the Pfizer vaccine,” that it “can ‘break through’ [the] vaccine,” and that “Pfizer Can’t Stop [the] Africa (sic) Strain.”
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



